Ensuring patients are heard and have the resources they need to have meaningful treatment or clinical trial discussions with their healthcare team is a priority for BeiGene as we strive to put patients first.

Ensuring patients are heard and have the resources they need to have meaningful treatment or clinical trial discussions with their healthcare team is a priority for BeiGene as we strive to put patients first.

This special edition blog features a conversation between Terry, a patient with the blood cancer chronic lymphocytic leukemia (CLL), and Lisa Porat, Oncology Social Worker and U.S. Lead, Patient Advocacy, BeiGene.

Dealing with a cancer diagnosis requires coping on multiple fronts. Integrating mind and body care becomes more than a concept—it becomes a powerful tool for healing and enhancing quality of life, both for individuals with cancer and their care partners.

After a cancer diagnosis, choosing a treatment becomes critical. It’s vital to understand the medications available. But how do these cancer treatments reach the market? Although the journey begins in the lab, it’s through clinical trials that these medicines become available to patients.

There is much to honor and celebrate in the month of June—summer is officially here, weather is beautiful, new scientific advancements are expanding in the news.

There is comfort as well as validation when someone takes the time to listen and hold space for our perspectives, experiences, and our life’s stories.